Celularity Inc (CELU)
2.76
-0.09
(-3.16%)
USD |
NASDAQ |
Nov 22, 16:00
2.77
+0.01
(+0.36%)
After-Hours: 20:00
Celularity Enterprise Value: 101.21M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 101.21M |
| November 21, 2024 | 103.19M |
| November 20, 2024 | 105.17M |
| November 19, 2024 | 104.73M |
| November 18, 2024 | 101.43M |
| November 15, 2024 | 94.61M |
| November 14, 2024 | 90.00M |
| November 13, 2024 | 118.58M |
| November 12, 2024 | 124.73M |
| November 11, 2024 | 115.72M |
| November 08, 2024 | 118.58M |
| November 07, 2024 | 108.46M |
| November 06, 2024 | 72.41M |
| November 05, 2024 | 74.61M |
| November 04, 2024 | 74.61M |
| November 01, 2024 | 72.19M |
| October 31, 2024 | 70.87M |
| October 30, 2024 | 75.27M |
| October 29, 2024 | 77.69M |
| October 28, 2024 | 78.10M |
| October 25, 2024 | 81.42M |
| October 24, 2024 | 88.46M |
| October 23, 2024 | 91.01M |
| October 22, 2024 | 87.68M |
| October 21, 2024 | 86.81M |
| Date | Value |
|---|---|
| October 18, 2024 | 95.71M |
| October 17, 2024 | 97.69M |
| October 16, 2024 | 101.65M |
| October 15, 2024 | 102.53M |
| October 14, 2024 | 101.43M |
| October 11, 2024 | 95.71M |
| October 10, 2024 | 96.15M |
| October 09, 2024 | 94.17M |
| October 08, 2024 | 92.64M |
| October 07, 2024 | 95.49M |
| October 04, 2024 | 98.88M |
| October 03, 2024 | 99.89M |
| October 02, 2024 | 99.45M |
| October 01, 2024 | 105.17M |
| September 30, 2024 | 105.83M |
| September 27, 2024 | 106.27M |
| September 26, 2024 | 106.49M |
| September 25, 2024 | 104.29M |
| September 24, 2024 | 104.73M |
| September 23, 2024 | 103.85M |
| September 20, 2024 | 106.05M |
| September 19, 2024 | 101.21M |
| September 18, 2024 | 96.81M |
| September 17, 2024 | 101.43M |
| September 16, 2024 | 101.87M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
67.36M
Minimum
Dec 26 2023
1.730B
Maximum
Apr 28 2022
360.27M
Average
152.93M
Median
Enterprise Value Benchmarks
| Eli Lilly and Co | 737.78B |
| Dentsply Sirona Inc | 5.651B |
| Ligand Pharmaceuticals Inc | 2.032B |
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.488M |
| Revenue (Quarterly) | 12.11M |
| Total Expenses (Quarterly) | 22.29M |
| EPS Diluted (Quarterly) | -0.30 |
| Gross Profit Margin (Quarterly) | 82.47% |
| Profit Margin (Quarterly) | -53.57% |
| Earnings Yield | -211.5% |
| Normalized Earnings Yield | -51.19 |